Journal: Journal of Dental Research
Article Title: Nine Novel PAX9 Mutations and a Distinct Tooth Agenesis Genotype-Phenotype
doi: 10.1177/0022034517729322
Figure Lengend Snippet: Functional studies of mutant PAX9 proteins. (A) Expression of wild-type and mutant PAX9 proteins detected by Western blot. (B) Relative messenger RNA (mRNA) expression levels of mutant PAX9 at 12 h posttransfection. (C) After treatment with actinomycin D, PAX9 mRNAs underwent decay. The mRNA stability is presented by the percentage of remaining mRNAs at 4 and 8 h posttreatment. *P < 0.05. (D) Subcellular localization of wild-type and mutant PAX9 proteins assessed by immunofluorescence. (E) The transcriptional activation abilities of PAX9 mutants on the BMP4 promoter assessed by luciferase reporter assay. **P < 0.01. (F) Binding of PAX9 mutants to the paired domain consensus sequence CD19-2 (A-ins) assessed by an electrophoretic mobility shift assay.
Article Snippet: The human PAX9 complementary DNA (cDNA) (accession number: {"type":"entrez-nucleotide","attrs":{"text":"NM_006194","term_id":"260656050","term_text":"NM_006194"}} NM_006194 ; Origene) was subcloned into the pCMV-C-Myc expression vector (Beyotime) between 5′-BamHI and 3′-EcoRI sites to generate the pCMV-PAX9-Myc wild-type plasmid.
Techniques: Functional Assay, Mutagenesis, Expressing, Western Blot, Immunofluorescence, Activation Assay, Luciferase, Reporter Assay, Binding Assay, Sequencing, Electrophoretic Mobility Shift Assay